Literature DB >> 696683

Serum enzyme tests in diseases of the liver and biliary tree.

G Ellis, D M Goldberg, R J Spooner, A M Ward.   

Abstract

Eight serum enzyme tests were performed over a three-year period in 1,147 cases of patients with suspected hepatobiliary disease, of whom 580 had identifiable primary disease of the liver or biliary system. Individually, aminotransferase assays did not provide good discrimination among the various categories of hepatobiliary disease, but when expressed as a ratio a useful degree of discrimination was obtained. Isocitrate dehydrogenase, guanase and glutamate dehydrogenase alone were poor discriminants of the various disease categories studied; combination of the latter enzyme with the aminotransferases in various ratios did not achieve worthwhile improvement. Adenosine deaminase was normal in most patients with extrahepatic obstruction and abnormal in most patients with parenchymal hepatic disease, and is potentially a useful test additional to the aminotransferases in routine diagnosis. 5'-Nucleotidase was more sensitive and specific than alkaline phosphatase in diagnosing hepatobiliary disorders. Abnormalities of all these enzymes were encountered in patients who did not have hepatobiliary disease, most frequently among subjects with cancer, diabetes mellitus, and diseases of the respiratory and cardiovascular systems.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 696683     DOI: 10.1093/ajcp/70.2.248

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  13 in total

Review 1.  Clinical use of serum enzymes in liver disease.

Authors:  J J Reichling; M M Kaplan
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

2.  Characterization of different molecular forms of 5'-nucleotidase in normal serum and in serum from cholestatic patients and bile-duct-ligated rats.

Authors:  N N Chuang; A C Newby; J P Luzio
Journal:  Biochem J       Date:  1984-12-15       Impact factor: 3.857

3.  A prospective study of the causes of notably raised aspartate aminotransferase of liver origin.

Authors:  M W Whitehead; N D Hawkes; I Hainsworth; J G Kingham
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

4.  5'-Nucleotidase activities in sera and liver tissues of viral hepatitis patients.

Authors:  M Fukano; S Amano; F Hazama; S Hosoda
Journal:  Gastroenterol Jpn       Date:  1990-04

5.  A randomized controlled trial to evaluate the effects of high-dose versus low-dose of arginine therapy on hepatic function tests in argininosuccinic aciduria.

Authors:  Sandesh C S Nagamani; Oleg A Shchelochkov; Mary A Mullins; Susan Carter; Brendan C Lanpher; Qin Sun; Soledad Kleppe; Ayelet Erez; E O'Brian Smith; Juan C Marini; Brendan Lee
Journal:  Mol Genet Metab       Date:  2012-09-17       Impact factor: 4.797

6.  The effect of chronic paracetamol administration to rats on the glycosaminoglycan content of patellar cartilage.

Authors:  P M van der Kraan; E L Vitters; B J de Vries; W B van den Berg; L B van de Putte
Journal:  Agents Actions       Date:  1990-03

7.  Serum glutamate dehydrogenase as a marker of hepatocyte necrosis in alcoholic liver disease.

Authors:  P R Mills; R J Spooner; R I Russell; P Boyle; R N MacSween
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-19

8.  Leucine amino peptidase a better indicator of carcinoma of liver, biliary tract and pancreas.

Authors:  M S Ghadge; A V Sirsat; M S Bhansali; L J Desouza; P Jagannath
Journal:  Indian J Clin Biochem       Date:  2001-01

9.  Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients.

Authors:  Timothy N A Archampong; Margaret Lartey; Kwamena W Sagoe; Adjoa Obo-Akwa; Ernest Kenu; Fizza S Gillani; Hongmei Yang; Isaac Boamah; Timothy Flanigan; Awewura Kwara
Journal:  BMC Infect Dis       Date:  2016-01-13       Impact factor: 3.090

10.  Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant.

Authors:  N O Ku; S Michie; R G Oshima; M B Omary
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.